Inventor · disambiguated record
Jeffrey Roger Roppe
Also filed as: ROPPE JEFFREY · ROPPE JEFFREY R · ROPPE JEFFREY ROGER
33 granted patents·18 pending applications·223 citations·filing 2002–2025
97Inventor score
Files withMERCK & CO INC8AMIRA PHARMACEUTICALS INC7HUTCHINSON JOHN HOWARD6PANMIRA PHARMACEUTICALS LLC6CONTINEUM THERAPEUTICS INC5
Top patents by PatentIndex Score
51 records- 0192US11752149B2Muscarinic acetylcholine M1 receptor antagonistsPIPELINE THERAPEUTICS INC·Filed 2020·Granted Sep 12, 2023·3 cites·2 claims
- 0292US8058300B2Polycyclic antagonists of lysophosphatidic acid receptorsHUTCHINSON JOHN HOWARD·Filed 2010·Granted Nov 15, 2011·20 cites·35 claims
- 0391US8067445B2N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptorsHUTCHINSON JOHN HOWARD·Filed 2009·Granted Nov 29, 2011·14 cites·31 claims
- 0489US9000025B2Autotaxin inhibitors and uses thereofROPPE JEFFREY ROGER·Filed 2011·Granted Apr 7, 2015·17 cites·20 claims
- 0589US8362044B2N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptorsPANMIRA PHARMACEUTICALS LLC·Filed 2011·Granted Jan 29, 2013·11 cites·21 claims
- 0689US8048902B2Antagonists of lysophosphatidic acid receptorsAMIRA PHARMACEUTICALS INC·Filed 2009·Granted Nov 1, 2011·13 cites·35 claims
- 0789US7834037B25-lipoxygenase-activating protein (FLAP) inhibitorsAMIRA PHARMACEUTICALS INC·Filed 2007·Granted Nov 16, 2010·11 cites·19 claims
- 0888US7977359B25-lipdxygenase-activating protein (FLAP) inhibitorsAMIRA PHARMACEUTICALS INC·Filed 2006·Granted Jul 12, 2011·11 cites·12 claims
- 0986US8609852B2Thiazolyl mGluR5 antagonists and methods for their useCOSFORD NICHOLAS D·Filed 2012·Granted Dec 17, 2013·12 cites·2 claims
- 1086US7462619B2Pyridazine, pyrimidine and pyrazine ethyne compoundsMERCK & CO INC·Filed 2005·Granted Dec 9, 2008·5 cites·2 claims
- 1185US11512090B2Muscarinic acetylcholine M1 receptor antagonistsPIPELINE THERAPEUTICS INC·Filed 2019·Granted Nov 29, 2022·4 cites·19 claims
- 1283US8524748B2Heteroalkyl biphenyl antagonists of prostaglandin D2 receptorsHUTCHINSON JOHN HOWARD·Filed 2009·Granted Sep 3, 2013·6 cites·20 claims
- 1383US8399666B25-lipoxygenase-activating protein (FLAP) inhibitorsHUTCHINSON JOHN H·Filed 2006·Granted Mar 19, 2013·10 cites·5 claims
- 1483US8273780B2Polycyclic antagonists of lysophosphatidic acid receptorsHUTCHINSON JOHN HOWARD·Filed 2011·Granted Sep 25, 2012·6 cites·16 claims
- 1582US8383654B2Heterocyclic antagonists of prostaglandin D2 receptorsPANMIRA PHARMACEUTICALS LLC·Filed 2009·Granted Feb 26, 2013·6 cites·18 claims
- 1682US8378107B2Heteroaryl antagonists of prostaglandin D2 receptorsPANMIRA PHARMACEUTICALS LLC·Filed 2009·Granted Feb 19, 2013·6 cites·19 claims
- 1782US7879882B2Thiazolyl mglur5 antagonists and methods for their useMERCK SHARP & DOHME·Filed 2005·Granted Feb 1, 2011·4 cites·2 claims
- 1881US7105548B2Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5MERCK & CO INC·Filed 2002·Granted Sep 12, 2006·15 cites·6 claims
- 1980US12054487B2Muscarinic acetylcholine M1 receptor antagonistsCONTINEUM THERAPEUTICS INC·Filed 2019·Granted Aug 6, 2024·2 cites·18 claims
- 2080US9260416B2Heterocyclic autotaxin inhibitors and uses thereofROPPE JEFFREY ROGER·Filed 2012·Granted Feb 16, 2016·6 cites·14 claims
- 2180US8440707B2Antagonists of lysophosphatidic acid receptorsHUTCHINSON JOHN HOWARD·Filed 2011·Granted May 14, 2013·4 cites·17 claims
- 2280US7253190B2Heteroaryl substituted tetrazole modulators of metabotrophic glutamate receptor-5MERCK & CO INC·Filed 2002·Granted Aug 7, 2007·14 cites·6 claims
- 2377US9849109B2Autotaxin inhibitors and uses thereofAMIRA PHARMACEUTICALS INC·Filed 2015·Granted Dec 26, 2017·2 cites·8 claims
- 2477US8049015B2Heteroaryl antagonists of prostaglandin D2 receptorsPANMIRA PHARMACEUTICALS LLC·Filed 2009·Granted Nov 1, 2011·3 cites·36 claims
- 2576US7268151B2Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5MERCK & CO INC·Filed 2004·Granted Sep 11, 2007·10 cites·6 claims
- 2674US12390462B2Muscarinic acetylcholine M1 receptor antagonistsCONTINEUM THERAPEUTICS INC·Filed 2023·Granted Aug 19, 2025·0 cites·6 claims
- 2773US7365074B2Pyridazine, pyrimidine and pyrazine ethyne compoundsMERCK & CO INC·Filed 2004·Granted Apr 29, 2008·5 cites·2 claims
- 2872US10730832B2Aliphatic prolinamide derivativesOrion Ophthalmology LLC·Filed 2017·Granted Aug 4, 2020·1 cites·16 claims
- 2972US2025026758A1Muscarinic acetylcholine m1 receptor antagonistsCONTINEUM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3068US8242143B2Thiazolyl mGluR5 antagonists and methods for their useCOSFORD NICHOLAS D·Filed 2011·Granted Aug 14, 2012·1 cites·8 claims
- 3162US7393959B2Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5MERCK & CO INC·Filed 2004·Granted Jul 1, 2008·1 cites·6 claims
- 3259US2013158036A1N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptorsPANMIRA PHARMACEUTICALS LLC·Filed 2012·Application pending·0 cites
- 3358US2025034110A1Lpar1 antagonists and uses thereofPIPELINE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3457US2024217981A1Crystalline compound of muscarinic acetylcholine m1 receptor antagonistsPIPELINE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3557US2025179045A1Lpar1 antagonists and uses thereofCONTINEUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3656US2025171455A1Muscarinic acetylcholine m1 receptor antagonistsCONTINEUM THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3752US2006252807A1Novel ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disordersKALYPSYS INC·Filed 2006·Application pending·0 cites
- 3851US2007060618A1Alkyne derivatives as tracers for metabotropic glutamate receptor bindingMERCK & CO INC·Filed 2003·Application pending·0 cites
- 3951US2011098352A1N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptorsAMIRA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4050US9987381B2Radioligands for imaging the LPA-1 receptorBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jun 5, 2018·0 cites·4 claims
- 4150US2010298343A15-lipoxygenase-activating protein (flap) inhibitorsHUTCHINSON JOHN HOWARD·Filed 2008·Application pending·0 cites
- 4250US2011034514A15-Lipoxygenase-Activating Protein (FLAP) InhibitorsAMIRA PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4348US2011118315A15-lipoxygenase-activating protein (flap) inhibitorsHUTCHINSON JOHN H·Filed 2011·Application pending·0 cites
- 4445US2010068301A1Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulatorsHUTCHINSON JOHN H·Filed 2007·Application pending·0 cites
- 4545US2007219206A15-lipoxygenase-activating protein (flap) inhibitorsAMIRA PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 4644US2005085523A1Imidazolyl and pyrazolyl ethyne compoundsFiled 2004·Application pending·0 cites
- 4743US7592337B2Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5MERCK & CO INC·Filed 2003·Granted Sep 22, 2009·0 cites·9 claims
- 4843US2008139558A1Quinolones useful as inducible nitric oxide synthase inhibitorsKALYPSYS INC·Filed 2007·Application pending·0 cites
- 4940US8541587B2Lysophosphatidic acid receptor antagonistsSEIDERS THOMAS JON·Filed 2012·Granted Sep 24, 2013·0 cites·18 claims
- 5036US2013005721A1Indolizine inhibitors of 5-lipoxygenasePANMIRA PHARMACEUTICALS LLC·Filed 2010·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →